This video was recorded during January 17, 2023
About the Speaker
Aria Vaishnavi, PhD
CPRIT Scholar of Cancer Research & Assistant Professor, Cancer Biology
MD Anderson UT
Dr. Aria Vaishnavi completed her doctoral studies at the University of Colorado Anschutz Medical Campus, where she focused on oncogenic gene fusions in lung cancer. She went on to do her postdoctoral fellowship with Dr. Martin McMahon at the University of Utah’s Huntsman Cancer Institute, where she studied mechanisms of lung cancer initiation and progression in mouse models of BRAF-mutant lung cancer. A few months ago, Dr. Vaishnavi began her independent research group and faculty appointment at the UT MD Anderson Cancer Center in Houston, Texas.
The Vaishnavi lab’s broad research interests focus on improving our understanding of the molecular mechanisms that drive initiation, maintenance, and progression of lung adenocarcinoma and to use those findings to identify innovative, clinically-relevant therapeutic approaches. We combine genetically engineered mouse models (GEMMs), patient-derived xenograft (PDX) models, and in vitro culture systems of lung cancer to identify mechanistically-based therapeutic approaches to be tested preclinically.
This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.
LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.